An update on combination product device development discussed at Pre-Filled Syringes San Francisco 2021 Read more
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis Read more
Moderna Announces Agreement with Thermo Fisher Scientific for Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine Read more
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility Read more
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder Read more
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis Read more
Nordic Capital acquires speciality pharmaceutical company ADVANZ PHARMA in deal worth ~ $846 million Read more